Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
ConocoPhillips
COP
|
$3.33B |
| 2 |
Merck
MRK
|
$2.61B |
| 3 |
Schlumberger
SLB
|
$1.65B |
| 4 |
Target
TGT
|
$1.34B |
| 5 |
General Mills
GIS
|
$926M |
Top Sells
| 1 |
Pfizer
PFE
|
$2.72B |
| 2 |
Blackrock
BLK
|
$2.48B |
| 3 |
US Bancorp
USB
|
$1.68B |
| 4 |
M&T Bank
MTB
|
$762M |
| 5 |
Huntington Bancshares
HBAN
|
$554M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3376
American Battery Technology Co
ABAT
$223M
| $71.4K | ﹤0.01% |
+69,331
| New | +$71.4K |
|
|
GCTS
3377
GCT Semiconductor Holding
GCTS
$75.4M
| $70.4K | ﹤0.01% |
42,932
| – | – |
|
3378
Douglas Elliman
DOUG
$230M
| $68.8K | ﹤0.01% |
40,001
+1
| +0% | +$2 |
|
3379
Genelux
GNLX
$127M
| $67.5K | ﹤0.01% |
+25,000
| New | +$67.5K |
|
3380
Drilling Tools International
DTI
$67.4M
| $67K | ﹤0.01% |
28,283
| – | – |
|
3381
CAMP4 Therapeutics Corporation Common Stock
CAMP
$31.5M
| $66.7K | ﹤0.01% |
16,685
| – | – |
|
3382
Rezolute
RZLT
$624M
| $66K | ﹤0.01% |
22,757
| – | – |
|
3383
United Homes Group
UHG
$246M
| $65.5K | ﹤0.01% |
23,396
+6,000
| +34% | +$16.8K |
|
3384
Upland Software
UPLD
$80.6M
| $65.1K | ﹤0.01% |
22,775
-25
| -0.1% | -$72 |
|
3385
Coya Therapeutics
COYA
$109M
| $64.7K | ﹤0.01% |
+10,000
| New | +$64.7K |
|
3386
Protara Therapeutics
TARA
$122M
| $63.9K | ﹤0.01% |
+15,000
| New | +$63.9K |
|
3387
FibroBiologics
FBLG
$26M
| $62.8K | ﹤0.01% |
69,805
+73
| +0.1% | +$66 |
|
|
LFT
3388
Lument Finance Trust
LFT
$118M
| $62.7K | ﹤0.01% |
24,035
| – | – |
|
|
VXRT
3389
DELISTED
Vaxart
VXRT
| $62.5K | ﹤0.01% |
153,547
| – | – |
|
|
RPT
3390
Rithm Property Trust Inc.
RPT
$117M
| $62.2K | ﹤0.01% |
+21,666
| New | +$62.2K |
|
3391
CuriosityStream
CURI
$258M
| $61.8K | ﹤0.01% |
23,041
| – | – |
|
|
BOLD
3392
Boundless Bio
BOLD
$25.7M
| $61.1K | ﹤0.01% |
40,458
| – | – |
|
3393
VistaGen Therapeutics
VTGN
$108M
| $58.3K | ﹤0.01% |
23,302
| – | – |
|
3394
PepGen
PEPG
$39.4M
| $56.3K | ﹤0.01% |
40,070
-8,281
| -17% | -$11.6K |
|
3395
Harvard Bioscience
HBIO
$21.8M
| $56K | ﹤0.01% |
98,883
-140,813
| -59% | -$79.7K |
|
|
GAN
3396
DELISTED
GAN Ltd
GAN
| $55.7K | ﹤0.01% |
31,476
| – | – |
|
3397
Neuronetics
STIM
$208M
| $55.2K | ﹤0.01% |
+15,000
| New | +$55.2K |
|
3398
TriSalus Life Sciences
TLSI
$257M
| $55.2K | ﹤0.01% |
+10,000
| New | +$55.2K |
|
3399
Tevogen Bio Holdings
TVGN
$175M
| $53.6K | ﹤0.01% |
49,644
+63
| +0.1% | +$68 |
|
|
WW
3400
DELISTED
WW International
WW
| $52K | ﹤0.01% |
99,577
| – | – |
|